Business Context and Reporting Period
This Form 8-K is a current report filed by Leap Therapeutics, Inc. (not Cypherpunk Technologies Inc.) on June 15, 2021. The filing details the results of the Company's 2021 Annual Meeting of Stockholders held on the same date. Leap Therapeutics is an emerging growth company incorporated in Delaware, with its common stock (LPTX) trading on the Nasdaq Global Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
The primary material event reported is the ratification of director elections and the appointment of the independent auditor. The specific voting outcomes were:
- Director Elections (Class I): Three nominees were elected to serve until the 2024 annual meeting.
- Monica Bertagnolli, MD, FASCO: 32,934,607 votes for; 1,630,963 votes withheld.
- James Cavanaugh, PhD: 32,695,663 votes for; 1,869,907 votes withheld.
- Douglas E. Onsi: 32,887,706 votes for; 1,677,864 votes withheld.
- Auditor Ratification: The appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified with 44,709,371 votes for, 432,541 votes against, and 57,542 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural results of the stockholder meeting.
Investor Verification Checklist
- Verify the correct registrant name is Leap Therapeutics, Inc., as the input metadata incorrectly referenced "Cypherpunk Technologies Inc."
- Confirm the tenure of the newly elected Class I directors extends through the 2024 annual meeting.
- Review the full proxy statement for detailed biographical information on the elected directors and the rationale for the auditor selection.
- Note the significant number of broker non-votes (10,633,884) recorded for the director elections.